Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level CProspective StudyPubMed
Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up.
Prospective Study on Immune Modulation, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy - Level BClinical TrialPubMed
Safety of adipose-derived stromal vascular fraction cells to treat Parkinson's disease.
Clinical Trial with a reported sample of 9 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Parkinsonism Relat Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 9
Parkinsonism Relat Disord2 citations - Level BClinical TrialPubMed
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy).
Clinical Trial with a reported sample of 18 on Chronic Kidney Disease, published in Stem Cells Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 18
Stem Cells Transl Med8 citations - Level BClinical TrialPubMed
Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year.
Clinical Trial with a reported sample of 51 on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
- 2021
- n = 51
Stem Cells Transl Med54 citations - Level CProspective StudyEurope PMC
Increased Release of Proinflammatory Proteins in Primary Human Adipocytes and Activation of the Inflammatory NFĸB, p38, and ERK Pathways upon Omentin Treatment
Prospective Study on Hip, published in Obes Facts (2020) — summary generated from the PubMed abstract.
- 2020
Obes Facts15 citations - Level CProspective StudyPubMed
Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: A 6-year follow-up showing durable effects.
Prospective Study with a reported sample of 10 on Ankle Injury, Cardiovascular Disease, Peripheral Artery Disease, published in Stem Cell Res (2020) — summary generated from the PubMed abstract.
- 2020
- n = 10
Stem Cell Res12 citations - Level CCase Report / SeriesPubMed
Sustained clinical improvement of Parkinson's disease in two patients with facially-transplanted adipose-derived stromal vascular fraction cells.
Case Report / Series on Neuroinflammation, published in J Clin Neurosci (2020) — summary generated from the PubMed abstract.
- 2020
J Clin Neurosci16 citations - Level CCase Report / SeriesPubMed
Assisted Salvage of Ischemic Fasciocutaneous Flap Using Adipose-Derived Mesenchymal Stem Cells: In-Situ Revascularization.
Case Report / Series on Peripheral Artery Disease, published in Aesthet Surg J (2017) — summary generated from the PubMed abstract.
- 2017
Aesthet Surg J4 citations - Level CProspective StudyPubMed
Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells.
Prospective Study on Ankle Injury, Chronic Wound, published in Stem Cell Res (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cell Res42 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406